Related Experiment Video
Updated: May 29, 2025

A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling
Anni Suominen1,2, Aino Suni1, Saku Ruohonen1
1Research Centre for Integrative Physiology & Pharmacology, Institute of Biomedicine University of Turku Finland.
Melanocortin 1 receptor (MC1R) deficiency in cardiomyocytes blunts cardiac hypertrophy. However, MC1R deficiency also leads to adverse cardiac remodeling. Activating MC1R promotes cardiomyocyte hypertrophy.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Receptor Signaling
Background:
- The melanocortin 1 receptor (MC1R) is known for its roles in skin pigmentation and immunity.
- MC1R expression has recently been identified in the heart, but its function in cardiac remodeling is unknown.
Purpose of the Study:
- To investigate the role of MC1R in pathological and physiological cardiac remodeling.
- To determine if MC1R influences cardiac hypertrophy and function.
Main Methods:
- Utilized global MC1R deficient mice (recessive yellow) and cardiomyocyte-specific MC1R knockout mice.
- Induced cardiac hypertrophy via transverse aortic constriction (pathological) and voluntary wheel running (physiological).
- Assessed cardiac structure and function using echocardiography, histology, and molecular analyses in vivo and in vitro.
Main Results:
- MC1R expression declines in failing hearts.
- MC1R deficiency in cardiomyocytes attenuated cardiac hypertrophy in response to pressure overload and exercise.
- MC1R knockout mice exhibited adverse remodeling, including left ventricular dilatation and reduced ejection fraction.
- Pharmacological MC1R activation promoted hypertrophy in cultured cardiomyocytes.
Conclusions:
- Cardiomyocyte-specific MC1R deficiency attenuates cardiac hypertrophy but can lead to detrimental remodeling.
- MC1R signaling in cardiomyocytes plays a dual role in cardiac adaptation to stress.
- Targeting MC1R may offer therapeutic potential for managing cardiac hypertrophy.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Cardiac Performance
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
